World's Leading Retina Organization Announces Launch of Journal of VitreoRetinal Diseases

Monday, January 30, 2017 General News
Email Print This Page Comment
Font : A-A+

CHICAGO, Jan. 30, 2017 /PRNewswire-USNewswire/ -- The American Society of Retina Specialists (ASRS) and SAGE Publishing announce

the inaugural issue of the Journal of VitreoRetinal Diseases (JVRD). The new scientific journal from the world's largest retina organization will provide unparalleled coverage of the rapidly growing universe of retina research.

"JVRD brings

to bear the ASRS's considerable breadth, vitality, credibility and reputation for excellence in capturing today's most important retina science, clinical information and thought leadership," said JVRD Editor-in-Chief, Donald J. D'Amico, MD.  View a message from Dr. D'Amico >>

The journal will feature original basic, translational and clinical research. Papers will be subject to a rigorous peer-review process initiated by JVRD 's notable international editorial board to assure the highest quality and eventual placement in key indexing systems such as PubMed.

The print and online publication will be circulated 6 times per year to a comprehensive audience of researchers and retina readers by subscription and as a free benefit to ASRS members worldwide.  Articles and supplemental multi-media content can be found at http://jvrd.sagepub.com.

The inaugural issue of JVRD includes the following articles:

  • The American Society of Retina Specialists 2016 Founders Award Lecture: Retinal Tumors: Understanding Clinical Features, OCT Morphology, and Therapy by Carol L. Shields, MD, and Jerry A. Shields, MD.
  • The Foundation of the American Society of Retina Specialists Presidents' Young Investigator Award Lecture: Solving AMD: Moving Forward by Stepping Back by Jayakrishna Ambati, MD.
  • Does Internal Limiting Membrane Peeling Size Matter? by David H. W. Steel, MBBS, FRCOphth; Yunzi Chen, MBBS; James Latimer, MBBS; Kathryn White, PhD; and Peter J. Avery, PhD.
  • Management of Large Submacular Hemorrhages Due to Exudative AMD Utilizing Pars Plan Vitrectomy, Subretinal Tissue Plasminogen Activator, and Gas Insertion Compared With Antivascular Endothelial Growth Factor Alone by Enchun M. Liu, MD; Rithwick Rajagopal, MD, PhD; Bradley T. Smith, MD; and M. Gilbert Grand, MD.
  • Prevalence of Different Optical Coherence Tomography Findings in Spanish Cohort With High Myopia by Miguel Ruão, MD; Maria Andreu-Fenoll, RN; Rosa Dolz-Marco, MD, FEBO; and Roberto Gallego-Pinazo, MD, PhD, FEBO.
  • Progression from No AMD to Intermediate AMD as Influenced by Antioxidant Treatment and Genetic Risk: An Analysis of Data From the Age-Related Eye Disease Study Cataract Trial by Carl C. Awh, MD; Brent Zanke, MD, PhD; and Rafal Kustra, PhD.
  • Epiretinal Membrane Peeling in Patients With Good Preoperative Vision by Nicholas D. Chinskey, MD, and Gaurav K. Shah, MD.
  • Cytomegalovirus Retinitis Outcomes in HIV-Infected and Non-HIV Patients as a Tertiary Care Center by Anton Orlin, MD; Jennifer Nadelmann, BS; Mrinali Gupta, MD; Sarju Patel, MD; Donald J. D'Amico, MD; R.V. Paul Chan, MD; Amanda Artis, MS, MP; and Szilárd Kiss, MD.
  • Simultaneous Dexamethasone Intravitreal Implant and Anti-VEGF Therapy for Neovascular Age-Related Macular Degeneration Resistant to Anti-VEGF Monotherapy by Bozho Todorich, MD, PhD; Aristomenis Thanos, MD; Yoshihiro Yonekawa, MD; Gerta Mane, MD; Madeleine Hasbrook, MD; Benjamin J. Thomas, MD; Maria A. Woodward, MD, MS; George A. Williams, MD; Antonio Capone, Jr., MD; Jeremy D. Wolfe, MD, MS; Lisa J. Faia, MD; and Tarek S. Hassan, MD, PhD.

      The issue also features Special Correspondences, Case Reports and Letters to the Editor. Link to complete issue.

      Authors seeking to submit papers are asked to visit https://mc.manuscriptcentral.com/jvrd. 

      ASRS Contact: Lydia.Steck@asrs.org

       

      To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/worlds-leading-retina-organization-announces-launch-of-journal-of-vitreoretinal-diseases-300398330.html

      SOURCE American Society of Retina Specialists



    Post your Comments

    Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
    * Your comment can be maximum of 2500 characters
    I agree to the terms and conditions

    News A - Z

    A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

    News Search

    Medindia Newsletters

    Subscribe to our Free Newsletters!

    Terms & Conditions and Privacy Policy.

    Press Release Category

    Press Release Archive

    Stay Connected

    • Available on the Android Market
    • Available on the App Store

    Facebook